Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SARS CoV 2 vaccine inactivated - Sinovac Biotech

Next Previous
Drug Profile

SARS CoV 2 vaccine inactivated - Sinovac Biotech

Alternative Names: Adsorbed COVID-19 Vaccine inactivated - Sinovac; Coronavac; CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated - Sinovac Biotech; CoronaVac®; COVID-19 vaccine - Sinovac Biotech; COVID-2019 vaccine - Sinovac Biotech; PiCoVacc; SARS-CoV-2 inactivated vaccine

Latest Information Update: 12 Dec 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sinovac Biotech
  • Developer PT Bio Farma; Sinovac Biotech
  • Class COVID-19 vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed COVID 2019 infections

Most Recent Events

  • 12 Dec 2025 SARS CoV 2 vaccine is still registered for COVID-2019 infections (In adolescents, In adults, In children, Prevention) in Thailand (IM)
  • 12 Dec 2025 SARS CoV 2 vaccine is still registered for COVID-2019 infections (Prevention) in Chile (IM)
  • 12 Dec 2025 SARS CoV 2 vaccine is still registered for COVID-2019 infections (Prevention, In adults) in Brazil (IM)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top